Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Tuebingen
About this trial
Despite being generally benign tumors, meningiomas are associated with an increased risk for thrombembolic complications after surgical resection. The molecular mechanisms underlying this circumstance are still unknown.
In this prospective observational trial, the investigators aim to evaluate the changes in coagulation and platelet function caused by tumor resection.
Blood samples are obtained by patients undergoing meningioma resection before and immediately after resection to detect said changes.
As a control cohort, blood samples are obtained from patients undergoing resection for glioma.
Eligibility criteria
Qualifiers
Patients undergoing resection for meningioma or
Patients undergoing resection for glioma or
Healthy controls
written consent for study participation
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 3 trial groupsSponsors and collaborators
Source ClinicalTrials.gov